Estimands in Oncology: Are we censoring for the right reason?
Publié le
Estimands Framework: Ensuring alignment between the key scientific question of interest, analysis and interpretation during clinical trial design. The estimands…
Designing a randomized trial with sample-size re-estimation: Challenges and Best Practices
Publié le
LEARN ON SAMPLE-SIZE RE-ESTIMATION, CONDITIONAL POWER AND THE PROMISING-ZONE METHOD. In this webinar, we will play the part of a sponsor consulting…
Bias and Randomization 1980 – 2020 – 2060
Publié le
Learn on history of bias and randomization in oncology clinical trials and how to think about what constitutes persuasive evidence…
Demystifying Clinical Systems Integration
Publié le
IDDI and XClinical webinar on the importance and the benefits Clinical Systems Integration WHAT YOU WILL LEARN: The importance and…
Statistical Considerations for Trials in Adjuvant Treatment of Colorectal Cancer
Publié le
Improvements in the treatment of patients with cancer largely depend on clinical trials comparing a new intervention with a previous…
Webinar: Clinical Trials for, and despite, COVID-19
Publié le
IDDI Complimentary Webinar on characteristics of Covid-19 trials and impact of the pandemic on clinical trials The current SARS-CoV-2-induced…
IDDI Complimentary Breakfast Webinar
Publié le
Drug development in oncology in the era of precision medicine 08:30am – 09:30am (CET), 19th NOVEMBER, 2020 WATCH THE RECORDED…
Medicon Valley Alliance: Q&A Interview with Erik Falvey from IDDI
Publié le
Recently, Erik Falvey, our Senior Director of Business Development, shared his insights during a Q&A session with Medicon Valley Alliance,…
Companion diagnostics and clinical development in oncology: a statistical perspective
Publié le
IDDI Complimentary Webinar on the need for integration of biomarker and IVD validation in clinical development Drug development in many…
Clinical endpoints and treatment effect in immuno-oncology
Publié le
IDDI Complimentary Webinar on Immuno-Oncology Immuno-oncology is a buoyant field of research, with recently developed drugs showing unprecedented response rates…